Xeltis raises an additional €20.5m to advance aXess™ toward FDA approval and US commercial launch with Horizon 3 Healthcare as the lead investor.
Amount Raised
€20.5 Million
Round Type
Venture
EindhovenManufacturingBiotechnologyHealth CareInvestors
Description
Xeltis announced it raised an additional €20.5m from new and existing shareholders to fund the ongoing US pivotal trial of aXess™, its pioneering living vascular access solution. The funding will also facilitate the FDA submission and commercial rollout in Europe. The company aims to enhance its manufacturing capabilities and continue the advancement of its clinical programs. This financing demonstrates robust investor confidence in Xeltis' strategy.
Quick answer
Xeltis raised €20.5 Million in a funding round, dated July 28, 2026. Investors: DaVita, Horizon 3 Healthcare, EQT Life Sciences, Vi Partners, Invest Nl and European Innovation Council. Xeltis is based in Eindhoven, North Brabant, Netherlands.
- How much did Xeltis raise?
- Xeltis raised €20.5 Million in a funding round on July 28, 2026.
- Who invested in Xeltis?
- DaVita, Horizon 3 Healthcare, EQT Life Sciences, Vi Partners, Invest Nl and European Innovation Council are named as investors in this round.
- What does Xeltis do?
- Xeltis is a medtech company developing transformative implants that enable the natural creation of living and long-lasting vessels.
- Where is Xeltis based and how big is it?
- Xeltis is based in Eindhoven, North Brabant, Netherlands. Fundz records about 85 employees.
- Who are the decision-makers at Xeltis?
- Fundz holds 2 contacts at Xeltis, including the Chief Executive Officer. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Manufacturing and Biotechnology around the same time
Companies in the same sectors as Xeltis that raised within 45 days of this round, from Fundz verified event records.
- Harvard Apparatus Regenerative Technology raised $2.8M (Post-IPO Equity) on September 11, 2026.
- Cerenome, Inc. raised $20M (Debt Financing) on September 10, 2026.
- Cerenome, Inc. raised $3M (Post-IPO Equity) on September 10, 2026.
- OpZira raised $2M (Seed) on September 9, 2026.
- Encision raised $80K (Post-IPO Equity) on September 8, 2026.
- Seraxis raised $10M on September 7, 2026.
Who to call at Xeltis, and when
A new round usually means Xeltis is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Xeltis raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Xeltis, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Xeltis. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Xeltis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Xeltis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.